Looking to Partner with the World CNS Series?
파트너십 안내서
Following a year of significant pharma acquisitions, approvals of transformative drugs the first of their kind, and a surge of financial backing to bolster innovation in new targets and preclinical pipelines, 2026 is set to continue this momentum, with more companies prioritizing neuroscience drug development than ever before.
If you have relevant capabilities in this space and would like to align your brand with the CNS community, contact us to promote your capabilities through a bespoke commercial package.
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
Download Your Copy of the Sponsorship Prospectus
Explore the Agenda
Hear the latest CNS innovations taking place within South Korea while hearing from global experts.
Partner With Us
Position yourself alongside other leading solution providers to ensure your company is the go-to service providers for Korean neuroscience drug developers.
Join Biopharma Experts
Be part of the hottest conversations with like-minded neuroscientists, C-level executives, heads, VPs, and more across discovery, translational and clinical development.